1
|
Mendes GD, Pereira TDS, Rodrigues JC, Santos EM, Souza MR, Lopes‐Martins RAB, Antunes NDJ, Moreno RA, De Nucci G. Comparative bioavailability of two zolpidem hemitartrate formulations in healthy human Brazilian volunteers using high‐performance liquid chromatography coupled to tandem mass spectrometry. Biomed Chromatogr 2020; 34:e4731. [DOI: 10.1002/bmc.4731] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2019] [Revised: 09/27/2019] [Accepted: 10/07/2019] [Indexed: 11/08/2022]
Affiliation(s)
- Gustavo D. Mendes
- Programa de Mestrado Profissional de Saúde e Meio Ambiente da Universidade Metropolitana de Santos Santos Brazil
- Department of Pharmacology, Faculdade São Leopoldo MandicInstituto de Pesquisas São Leopoldo Mandic Campinas Brazil
| | - Thais da Silva Pereira
- Department of Pharmacology, Faculty of Medical SciencesState University of Campinas (UNICAMP) Campinas/SP Brazil
| | - Júlio César Rodrigues
- Programa de Mestrado Profissional de Saúde e Meio Ambiente da Universidade Metropolitana de Santos Santos Brazil
| | - Elaine Marcílio Santos
- Programa de Mestrado Profissional de Saúde e Meio Ambiente da Universidade Metropolitana de Santos Santos Brazil
| | - Mariani Rafaela Souza
- Programa de Mestrado Profissional de Saúde e Meio Ambiente da Universidade Metropolitana de Santos Santos Brazil
| | - Rodrigo Alvaro Brandão Lopes‐Martins
- Laboratory of Biophotonics and Experimental Therapeutics, Instituto de Pesquisa & Desenvolvimento – IP&DUniversidade do Vale do Paraíba São José dos Campos Brazil
| | - Natalícia de Jesus Antunes
- Department of Pharmacology, Faculty of Medical SciencesState University of Campinas (UNICAMP) Campinas/SP Brazil
| | | | - Gilberto De Nucci
- Department of Pharmacology, Faculty of Medical SciencesState University of Campinas (UNICAMP) Campinas/SP Brazil
- Programa de Mestrado Profissional de Saúde e Meio Ambiente da Universidade Metropolitana de Santos Santos Brazil
- Department of Pharmacology, Faculdade São Leopoldo MandicInstituto de Pesquisas São Leopoldo Mandic Campinas Brazil
| |
Collapse
|
2
|
Krämer M, Heese P, Banger M, Madea B, Hess C. Range of therapeutic prothipendyl and prothipendyl sulfoxide concentrations in clinical blood samples. Drug Test Anal 2017; 10:1009-1016. [PMID: 29027369 DOI: 10.1002/dta.2319] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2017] [Revised: 09/27/2017] [Accepted: 09/28/2017] [Indexed: 11/09/2022]
Abstract
Due to a lack of reference blood concentrations in the literature, the forensic evaluation of prothipendyl findings in blood samples is difficult. Interpretations with regard to the assessment of blood concentrations as well as an estimation of the ingested prothipendyl amounts were often vague. To describe a concentration range in clinical samples, prothipendyl and prothipendyl sulfoxide concentrations were determined in serum samples of 50 psychiatric patients receiving 40 mg, 80 mg, or 160 mg doses of prothipendyl. The analyses of prothipendyl and prothipendyl sulfoxide were carried out using validated methods of high performance liquid chromatography coupled to triple quadrupole mass spectrometry (LC-QQQ-MS), respectively. 40 mg doses caused average prothipendyl serum concentrations of 18.0 ng/mL (1 hour after intake) and 7.9 ng/mL (10.5 hours after intake), while 80 mg doses caused averages of 42.6 ng/mL and 15.2 ng/mL at the mentioned times of sampling. Irrespective of the given dose, prothipendyl concentrations below 30 ng/mL were observed in 80% of the patient samples taken 1 hour after ingestion as well as in 90% of the samples collected 10.5 hours after administration. Serum concentrations of the Phase I metabolite prothipendyl sulfoxide averaged 4.3 ng/mL (1 hour after intake) and 3.6 ng/mL (10.5 hours after intake). Possible drug-drug interactions regarding absorption and metabolism of prothipendyl are discussed. Results of the herein presented study are useful for the interpretation of analytical prothipendyl findings in forensic toxicology. The utility of the described concentration range is demonstrated by discussing two death cases involving prothipendyl findings.
Collapse
Affiliation(s)
- Michael Krämer
- Institute of Forensic Medicine, Department of Forensic Toxicology, University Bonn, Germany
| | - Peter Heese
- Department of Addiction Disorders and Psychotherapy, LVR Hospital Bonn, Germany
| | - Markus Banger
- Department of Addiction Disorders and Psychotherapy, LVR Hospital Bonn, Germany
| | - Burkhard Madea
- Institute of Forensic Medicine, Department of Forensic Toxicology, University Bonn, Germany
| | - Cornelius Hess
- Institute of Forensic Medicine, Department of Forensic Toxicology, University Bonn, Germany
| |
Collapse
|
3
|
Krämer M, Broecker S, Madea B, Hess C. Confirmation of metabolites of the neuroleptic drug prothipendyl using human liver microsomes, specific CYP enzymes and authentic forensic samples-Benefit for routine drug testing. J Pharm Biomed Anal 2017; 145:517-524. [PMID: 28756170 DOI: 10.1016/j.jpba.2017.07.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2017] [Revised: 07/07/2017] [Accepted: 07/10/2017] [Indexed: 11/29/2022]
Abstract
Metabolism of the tricyclic azaphenothiazine neuroleptic drug prothipendyl was investigated with in vitro studies using human liver microsomes but also specific isoforms of cytochrome P450 (CYP) enzymes. Identification and analysis of metabolites was done by liquid chromatography (LC) coupled with quadrupole time of flight mass spectrometry (LC-QTOF-MS) as well as triple quadrupole mass spectrometry (LC-QQQ-MS). Results of the herein presented study revealed the proof of various demethylated and oxidized metabolites (-CH2, -C2H4, four derivatives of prothipendyl +O and three derivatives of prothipendyl -CH2+O). Metabolic reactions of prothipendyl were mainly catalyzed by CYP enzymes CYP1A2, CYP2D6, CYP2C19 and CYP3A4. N-demethyl-prothipendyl was predominantly formed by isoforms CYP2C19 and CYP1A2, while particularly the CYP isoenzyme 3A4 was responsible for the formation of prothipendyl sulfoxide. To confirm the formation of previously identified metabolites in vivo, cardiac blood samples that were tested positive for prothipendyl during routine drug testing and serum and urine samples, collected after a voluntary intake of prothipendyl, were analyzed by LC-QQQ-MS. All metabolites of prothipendyl were proven in these authentic specimens. Neither in serum samples nor in urine samples, a prolonged detectability of metabolites in comparison to prothipendyl could be demonstrated.
Collapse
Affiliation(s)
- M Krämer
- University Bonn, Institute of Forensic Medicine, Department of Forensic Toxicology, Stiftsplatz 12, 53111 Bonn, Germany.
| | - S Broecker
- Broeckers Solutions - Consulting and Support, Dyrotzer Straße 8, 13583 Berlin, Germany.
| | - B Madea
- University Bonn, Institute of Forensic Medicine, Department of Forensic Toxicology, Stiftsplatz 12, 53111 Bonn, Germany.
| | - C Hess
- University Bonn, Institute of Forensic Medicine, Department of Forensic Toxicology, Stiftsplatz 12, 53111 Bonn, Germany.
| |
Collapse
|
4
|
Byeon JY, Lee HI, Lee YJ, Lee JE, Kim SH, Kim YH, Na HS, Jang CG, Lee SY. Determination of zolpidem in human plasma by liquid chromatography-tandem mass spectrometry for clinical application. J Chromatogr B Analyt Technol Biomed Life Sci 2015; 986-987:129-34. [PMID: 25728370 DOI: 10.1016/j.jchromb.2015.02.004] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2014] [Revised: 01/27/2015] [Accepted: 02/02/2015] [Indexed: 10/24/2022]
Abstract
Zolpidem (ZPD) is widely described for the short-term treatment of insomnia. We have developed and validated a simple and rapid liquid chromatography analytical method using tandem mass spectrometry (LC-MS/MS) for the quantification of ZPD in human plasma. Using dibucaine as an internal standard (IS), the analyte was extracted with methyl t-butyl ether (MTBE). Chromatographic separation of ZPD was performed on a reversed-phase Luna C18 column (50 mm × 2.0 mm i.d., 5 μm particles) with a mobile phase of 10mM ammonium formate buffer (pH 3.0)-methanol (15:85, v/v) at a flow rate of 250 μm/min. The total run-time was 2.5 min and the retention times of ZPD and IS were 0.66 and 0.74 min, respectively. The mass-to-charge transition monitored for quantification of ZPD and IS was 308.2→235.2 and 344.0→271.0, respectively. The lower limit of quantification (LLOQ) using 100 μL of human plasma was 0.05 ng/mL and the calibration curves were linear over a range of 0.05-200 ng/mL (r(2)>0.9964). The mean accuracy and precision for intra- and inter-run validation of ZPD were within acceptable limits. In the present LC-MS/MS method, we showed improved sensitivity for quantification of the ZPD in human plasma using lower volume of plasma compared with previously described analytical methods for ZPD. This validated method was successfully applied to a pharmacokinetic study in humans.
Collapse
Affiliation(s)
- Ji-Yeong Byeon
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Hye-In Lee
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Yun-Jeong Lee
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea; College of Pharmacy, Dankook University, Cheonan 330-714, Republic of Korea
| | - Jung-Eun Lee
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Se-Hyung Kim
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Young-Hoon Kim
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Han-Sung Na
- National Institute of Food and Drug Safety Evaluation, MFDS, Cheongwon-gun, 363-951, Republic of Korea
| | - Choon-Gon Jang
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea
| | - Seok-Yong Lee
- School of Pharmacy, Sungkyunkwan University, Suwon 440-746, Republic of Korea.
| |
Collapse
|
5
|
Development and Validation of a Reversed-Phase HPLC Method for the Estimation of Zolpidem in Bulk Drug and Tablets. J CHEM-NY 2013. [DOI: 10.1155/2013/357890] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
In the present study an isocratic reversed-phase high-performance liquid chromatography method was developed for the estimation of zolpidem in bulk drug and pharmaceutical dosage forms. The quantification was carried out on C18columns. A mixture of acetonitrile-ammonium acetate (pH=8.0, 0.02 M) (60 : 40 v/v) was used as the mobile phase, at flow rate of 1.0 mL/min and the determination wavelength at 245 nm. The retention time of zolpidem was found to be 3–5 min. The validation of the proposed method was carried out for specificity, linearity, accuracy, precision, limit of detection, limit of quantification, and robustness. The linear dynamic range was from 2.5 to 30 μg mL−1. Regression equation was found to bey=0.1416x+0.0183with correlation coefficientr=0.9996. The percentage recovery obtained for zolpidem was greater than 96.5%. Limit of quantification and limit of detection were found to be 2.5 μg mL−1and 0.83 μg mL−1, respectively. The developed method can be used for routine quality control analysis of zolpidem in tablet formulations.
Collapse
|
6
|
Stanke F, Jourdil N, Lauby V, Bessard G. Zopiclone and Zolpidem Quantification in Human Plasma by High Performance Liquid Chromatography with Photo-Diode-Array Detection. J LIQ CHROMATOGR R T 2006. [DOI: 10.1080/10826079608014043] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Affiliation(s)
- F. Stanke
- a Laboratoire de Pharmacologie , C. H. U. Grenoble , B. P. 217, 38043, Grenoble, Cedex, 9, France
| | - N. Jourdil
- a Laboratoire de Pharmacologie , C. H. U. Grenoble , B. P. 217, 38043, Grenoble, Cedex, 9, France
| | - V. Lauby
- a Laboratoire de Pharmacologie , C. H. U. Grenoble , B. P. 217, 38043, Grenoble, Cedex, 9, France
| | - G. Bessard
- a Laboratoire de Pharmacologie , C. H. U. Grenoble , B. P. 217, 38043, Grenoble, Cedex, 9, France
| |
Collapse
|
7
|
Bhatt J, Jangid A, Shetty R, Shah B, Kambli S, Subbaiah G, Singh S. Quantification of zolpidem in human plasma by liquid chromatography–electrospray ionization tandem mass spectrometry. Biomed Chromatogr 2006; 20:736-42. [PMID: 16240286 DOI: 10.1002/bmc.589] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
A simple and robust method for quantification of zolpidem in human plasma has been established using liquid chromatography-electrospray ionization tandem mass spectrometry (LC-ESI MS/MS). Es-citalopram was used as an internal standard. Zolpidem and internal standard in plasma sample were extracted using solid-phase extraction cartridges (Oasis HLB, 1 cm3/30 mg). The samples were injected into a C8 reversed-phase column and the mobile phase used was acetonitrile-ammonium acetate (pH 4.6; 10 mm) (80:20, v/v) at a flow rate of 0.7 mL/min. Using MS/MS in the selected reaction-monitoring (SRM) mode, zolpidem and Es-citalopram were detected without any interference from human plasma matrix. Zolpidem produced a protonated precursor ion ([M+H]+) at m/z 308.1 and a corresponding product ion at m/z 235.1. The internal standard produced a protonated precursor ion ([M+H]+) at m/z 325.1 and a corresponding product ion at m/z 262.1. Detection of zolpidem in human plasma by the LC-ESI MS/MS method was accurate and precise with a quantification limit of 2.5 ng/mL. The proposed method was validated in the linear range 2.5-300 ng/mL. Reproducibility, recovery and stability of the method were evaluated. The method has been successfully applied to bioequivalence studies of zolpidem.
Collapse
Affiliation(s)
- Jignesh Bhatt
- Torrent Research Centre, Torrent Pharmaceuticals Limited, Village-Bhat, Gandhinagar-382428, Gujarat State, India.
| | | | | | | | | | | | | |
Collapse
|
8
|
Nirogi RVS, Kandikere VN, Shrivasthava W, Mudigonda K. Quantification of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection. Biomed Chromatogr 2006; 20:1103-8. [PMID: 16703647 DOI: 10.1002/bmc.652] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
A simple, reliable HPLC method with fluorescence detection (excitation 320 and emission 388 nm) was developed and validated for quantitation of zolpidem in human plasma. Following a single-step liquid-liquid extraction, the analyte and internal standard (quinine) were separated using an isocratic mobile phase on a reversed-phase C(18) column. The lower limit of quantitation was 1.8 ng/mL, with a relative standard deviation of less than 5%. A linear dynamic range of 1.8-288 ng/mL was established. This HPLC method was validated with between-batch and within-batch precision of 1.7-4.8 and 1.2-2.3%, respectively. The between-batch and within-batch accuracy was 95.3-100.4 and 95.5-102.7%, respectively. Frequently coadministered drugs did not interfere with the described methodology. Stability of zolpidem in plasma was excellent, with no evidence of degradation during sample processing (autosampler) and 30 days storage in a freezer. This validated method is simple and repeatable enough to be used in pharmacokinetic studies.
Collapse
Affiliation(s)
- Ramakrishna V S Nirogi
- Biopharmaceutical Research, Suven Life Sciences Ltd, Serene Chambers, Road 7, Banjara Hills, Hyderabad 500034, India.
| | | | | | | |
Collapse
|
9
|
Laviana L, Mangas C, Fernández-Marí F, Bayod M, Blanco D. Determination and in-process control of zolpidem synthesis by high-performance liquid chromatography. J Pharm Biomed Anal 2004; 36:925-8. [PMID: 15533692 DOI: 10.1016/j.jpba.2004.08.025] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2004] [Revised: 08/27/2004] [Accepted: 08/28/2004] [Indexed: 11/25/2022]
Abstract
A high-performance liquid chromatographic assay with diode-array detection has been developed for the in-process control of zolpidem synthesis and for the analysis of the drug and its synthetic intermediates. The separation uses a 4.6mm i.d. reversed-phase Kromasil C(18) (150 mm) column, 5 microm particle size with a gradient elution mode of acetonitrile and 0.02 M NH(4)OAc (adjusted to pH 8.0) as the mobile phase (flow rate 1.0 mlmin(-1)). The analysis is performed in 12 min. The method is simple, rapid and highly specific.
Collapse
Affiliation(s)
- L Laviana
- Department of Physical and Analytical Chemistry, University of Oviedo, Química Física y Analítica, Julian Clavería, Oviedo, Spain
| | | | | | | | | |
Collapse
|
10
|
El Zeany BA, Moustafa AA, Farid NF. Determination of zolpidem hemitartrate by quantitative HPTLC and LC. J Pharm Biomed Anal 2003; 33:393-401. [PMID: 14550858 DOI: 10.1016/s0731-7085(03)00243-7] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Two methods are described for the determination of zolpidem hemitartrate in presence of its degradation product. The first method was a TLC-UV densitometric one in which the mobile phase methanol: water (20:80) was used for developing the TLC plates. The R(f) of zolpidem hemitartrate was found to be 0.29+/-0.01 and that of its degradation product was 0.59+/-0.01. Linearity range was 0.5-4 microg/spot with mean recovery percentage (99.98+/-0.988)%. The second method was an HPLC method. HPLC was performed on a Bondapack C(18) column. The mobile phase was composed of a mixture of acetonitrile-0.01 M KH(2)PO(4) (40:60). The pH was adjusted to 3.5+/-0.1. Flow rate was 1.2 ml/min. Calibration graphs were linear in the range of 0.5-5 microg/ml with UV detection at 245 nm. Both methods have been successfully applied to pharmaceutical formulations. The results obtained were statistically compared with those obtained by applying the reported methods.
Collapse
Affiliation(s)
- B A El Zeany
- Department of Analytical Chemistry, Faculty of Pharmacy, Cairo University, 23 El-ahrar St, Cairo, Egypt
| | | | | |
Collapse
|
11
|
Ring PR, Bostick JM. Validation of a method for the determination of zolpidem in human plasma using LC with fluorescence detection. J Pharm Biomed Anal 2000; 22:495-504. [PMID: 10766367 DOI: 10.1016/s0731-7085(99)00311-8] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
A sensitive and selective high-performance liquid chromatography (HPLC) method was developed for the determination of zolpidem in human plasma. Zolpidem and the internal standard (trazodone) were extracted from human plasma that had been made basic. The basic sample was loaded onto a conditioned Bond Elut C18 cartridge, rinsed with water and eluted with methanol. Forty microliters were then injected onto the LC system. Separation was achieved on a C18 column (150 x 4.6 mm, 5 microm) with a mobile phase composed of acetonitrile:50 mM potassium phosphate monobasic at pH 6.0 (4:6, v/v). Detection was by fluorescence, with excitation at 254 nm and emission at 400 nm. The retention times of zolpidem and internal standard were approximately 4.7 and 5.3 min, respectively. The LC run time was 8 min. The assay was linear in concentration range 1-400 ng/ml for zolpidem in human plasma. The analysis of quality control samples for zolpidem (3, 30, and 300 ng/ml) demonstrated excellent precision with relative standard deviations (RSD) of 3.7, 4.6, and 3.0%, respectively (n = 18). The method was accurate with all intraday (n = 6) and overall (n = 18) mean concentrations within 5.8% from nominal at all quality control sample concentrations. This method was also performed using a Gilson Aspec XL automated sample processor and autoinjector. The samples were manually fortified with internal standard and made basic. The aspec then performed the solid phase extraction and made injections of the samples onto the LC system. Using the automated procedure for analysis, quality control samples for zolpidem (3, 30, and 300 ng/ml) demonstrated acceptable precision with RSD values of 9.0, 4.9, and 5.1%, respectively (n = 12). The method was accurate with all intracurve (n = 4) and overall (n = 12) mean values being less than 10.8% from nominal at all quality control sample concentrations.
Collapse
Affiliation(s)
- P R Ring
- Department of Bioanalytical Chemistry, Covance Laboratories Inc., Madison, WI 53704, USA.
| | | |
Collapse
|
12
|
Keller T, Schneider A, Tutsch-Bauer E. GC/MS determination of zolpidem in postmortem specimens in a voluntary intoxication. Forensic Sci Int 1999; 106:103-8. [PMID: 10664896 DOI: 10.1016/s0379-0738(99)00185-1] [Citation(s) in RCA: 30] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
An ingestion of an unknown quantity of Ivadal (zolpidem) tablets in a case of drug abuse is described. The authors report a new and fast method of analysing and determining the zolpidem concentration in postmortem specimens. Quantitation of zolpidem was performed by ethyl acetate extraction from alkalinized body fluids before GC/MS analysis. The analyses were performed without any complex sample clean-up steps and with little sample material. Postmortem concentrations of zolpidem in body fluids are given. The proposed method is a rapid procedure of analysis in cases of deliberate poisoning with the sedative-hypnotic drug, zolpidem.
Collapse
Affiliation(s)
- T Keller
- Institute of Forensic Medicine, Paris-Lodron University, Salzburg, Austria
| | | | | |
Collapse
|
13
|
Wang Q, Sun L, Lau CE. Determination of zolpidem in serum microsamples by high-performance liquid chromatography and its application to pharmacokinetics in rats. JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL SCIENCES AND APPLICATIONS 1999; 734:299-305. [PMID: 10595727 DOI: 10.1016/s0378-4347(99)00376-x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
A single-solvent extraction step high-performance liquid chromatographic method is described for quantitating zolpidem in rat serum microsamples (50 microl). The separation used a 2.1 mm I.D. reversed-phase OD-5-100 C18 column, 5 microm particle size with an isocratic mobile phase consisting of methanol-acetonitrile-26 mM sodium acetate buffer (adjusted to pH 2.0 with 40% phosphoric acid) containing 0.26 mM tetrabutylammonium phosphate (13:10:77, v/v/v). The detection limit was 3 ng/ml for zolpidem using an ultraviolet detector operated at 240 nm. The recovery was greater than 87% with analysis performed in 12 min. The method is simple, rapid, and applicable to pharmacokinetic studies of zolpidem after administering two intravenous bolus doses (1 and 4 mg/kg) in rats.
Collapse
Affiliation(s)
- Q Wang
- Capital University of Medical Sciences, Department of Chemistry, School of Basic Sciences, Beijing, People's Republic of China
| | | | | |
Collapse
|
14
|
|
15
|
Stanke F, Jourdil N, Bessard J, Bessard G. Simultaneous determination of zolpidem and zopiclone in human plasma by gas chromatography-nitrogen-phosphorus detection. JOURNAL OF CHROMATOGRAPHY. B, BIOMEDICAL APPLICATIONS 1996; 675:43-51. [PMID: 8634767 DOI: 10.1016/0378-4347(95)00311-8] [Citation(s) in RCA: 26] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
A simple, specific and selective method for the simultaneous determination of zolpidem and zopiclone in human plasma is described. After a liquid-liquid extraction, the extract is injected into a capillary gas chromatograph with an OV-1 fused-silica column coupled to a nitrogen-phosphorus detector. The detection limits are 1 and 2 ng/ml for zolpidem and zopiclone, respectively. The method described is reproducible and linear over a range of concentrations, rendering it suitable for use for pharmacokinetic studies or toxicological evaluations. Absolute identification of the chromatographed compounds is accomplished by gas chromatography--mass spectrometry in both electron-impact and positive-ion chemical ionisation modes.
Collapse
Affiliation(s)
- F Stanke
- Laboratoire de Pharmacologie, Centre Hospitalier Universitaire de Grenoble, France
| | | | | | | |
Collapse
|
16
|
Tracqui A, Kintz P, Mangin P. High-performance liquid chromatographic assay with diode-array detection for toxicological screening of zopiclone, zolpidem, suriclone and alpidem in human plasma. JOURNAL OF CHROMATOGRAPHY 1993; 616:95-103. [PMID: 8104192 DOI: 10.1016/0378-4347(93)80476-k] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
A high-performance liquid chromatographic assay with diode-array detection has been developed for the toxicological screening of the newly developed non-benzodiazepine hypnotics and anxiolytics zopiclone, zolpidem, suriclone and alpidem. After single-step liquid-liquid extraction of plasma at pH 9.5 using chloroform-2-propanol-n-heptane (60:14:26, v/v), the substances are separated on a Nova-Pak C18 4-microns column (300 mm x 3.9 mm, I.D.), with methanol-tetrahydrofuran-pH 2.6 phosphate buffer (65:5:30, v/v) as the mobile phase (flow-rate 0.8 ml/min). Full ultraviolet spectra from 200 to 400 nm are recorded on-line during the entire analysis and may be automatically compared to spectra stored in a library. The retention times of the four drugs are 4.05 min (zopiclone), 4.66 min (zolpidem), 6.74 min (suriclone) and 10.97 min (alpidem). The analysis is performed in 15 min. The method is simple, rapid and highly specific. It is the first assay to be described for convenient screening of cyclopyrrolones and imidazopyridines.
Collapse
Affiliation(s)
- A Tracqui
- Institut de Médecine Légale, Faculté de Médecine de Strasbourg, France
| | | | | |
Collapse
|
17
|
Ascalone V, Flaminio L, Guinebault P, Thénot JP, Morselli PL. Determination of zolpidem, a new sleep-inducing agent, and its metabolites in biological fluids: pharmacokinetics, drug metabolism and overdosing investigations in humans. JOURNAL OF CHROMATOGRAPHY 1992; 581:237-50. [PMID: 1452614 DOI: 10.1016/0378-4347(92)80277-w] [Citation(s) in RCA: 35] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
For the determination of zolpidem, a new sleep inducer, and its metabolites in human plasma and urine, three methods were developed that are suitable for pharmacokinetics, drug metabolism and overdosing investigations. The methods used for pharmacokinetic and drug metabolism studies are based on column-switching high-performance liquid chromatography; they do not require any sample manipulation because the plasma or diluted urine is injected into a pre-column where clean-up and preconcentration take place. The analytes are transferred by valve-switching to the C18 analytical column for chromatography. To investigate overdose cases, urine samples only are used: the method is simple, because the diluted urine can be injected directly into the analytical column (phenyl type). This allows the identification and quantification of the principal urinary metabolite of zolpidem, the unchanged drug being practically undetectable. All the methods use fluorescence detection, which affords high sensitivity and selectivity. It is necessary to use a method capable of the determination of metabolites even if these are apparently pharmacologically inactive, because in different physiopathological populations the qualitative and quantitative metabolic profiles of zolpidem could be different. The method designed for the investigation of (accidental or deliberate) overdose cases is, as required on such occasions, simple and rapid, with good selectivity with respect to commonly prescribed psychotropic drugs.
Collapse
Affiliation(s)
- V Ascalone
- Synthélabo Recherche (L.E.R.S.), Department of Clinical Research, Limito, Italy
| | | | | | | | | |
Collapse
|